FWM
WST icon

FFT Wealth Management’s West Pharmaceutical WST Stock Holding History

FFT Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,811
Closed -$593K – 200
2024
Q4 		$593K Buy
+1,811
New +$570K 0.04% 86
2021
Q3 		– Sell
-127
Closed -$46K – 246
2021
Q2 		$46K Buy
+127
New +$42K 0.01% 138

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

FFT Wealth Management's WST Position: Q1 2025 in Review

FFT Wealth Management sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 1,811 shares — an estimated $593K sold.

FFT Wealth Management first reported a position in WST in Q2 2021 and held it in 2 quarters. The position peaked at $593K in Q4 2024. 713 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • FFT Wealth Management reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • FFT Wealth Management sold 1,811 West Pharmaceutical shares in Q1 2025, an estimated $593K.
  • FFT Wealth Management first reported a position in West Pharmaceutical in Q2 2021 and held it in 2 quarters.
  • FFT Wealth Management's West Pharmaceutical position peaked at $593K in Q4 2024.
  • 713 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on FFT Wealth Management's 13F filing for Q1 2025, filed 15 May 2025.